Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
Viatris’ Acquisition of Oyster Point Pharma
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
Fernweh’s Controlling Interest Acquisition in AZZ
Cooley advised affiliates of Fernweh Group on the deal. Fernweh Group announced its definitive agreement with AZZ. On June 23, Fernweh and AZZ jointly announced their entry...
Snyk’s Acquisition of Fugue
Cooley advised Snyk on the deal. Snyk, a leader in developer security, announced its acquisition of Fugue, a cloud security and compliance company. This milestone marks Snyk’s...
Nurx’s Merger with Thirty Madison
Fenwick & West and Jones Day advised Nurx on the deal while Cooley and Foley & Lardner LLP advised Thirty Madison. Nurx, a female-focused digital healthcare...
Lumentum’s $918 Million Acquisition of NeoPhotonics
Cooley LLP advised NeoPhotonics on the deal. NeoPhotonics, a developer and manufacturer of optoelectronic solutions, announced its agreement to sell to Lumentum for $918 million. The acquisition...
Datadog’s Acquisition of Sqreen
Cooley LLP advised Datadog on the deal. Datadog, the monitoring and security platform for cloud applications, announced its agreement to acquire Sqreen, a SaaS-based security platform that enables...